Form 4 for CDNA CareDx, Inc.
Accepted 2023-04-13 00:00:00 ET · period of report 2023-04-11 · accession 0001217234-23-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-13 | 2023-04-11 | CDNA | Maag Peter | Dir | A - Grant | $0.00 | +1,256 | 296.7K | +0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-11 | A | A | 1,256 | $0.00 | 296,724 | D | — | — | (F1) Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. (F2) The Reporting Person no longer has a reportable beneficial interest in an aggregate of 2,000 shares of the Issuer's common stock held as UTMA custodian for minor children included in the Reporting Person's prior ownership reports as such children are no longer minors. |